Medicine & Life Sciences
Squamous Cell Carcinoma of Head and Neck
100%
Leishmania donovani
83%
Nitric Oxide Synthase Type II
62%
Proto-Oncogene Proteins B-raf
48%
Aurora Kinases
45%
Mutation
44%
Phosphatidylinositol 3-Kinases
44%
Antigens
41%
Dasatinib
40%
Squamous Cell Carcinoma
40%
Leishmaniasis
38%
Liposomes
34%
Cell Line
34%
Leishmaniasis Vaccines
33%
Nitric Oxide Synthase
33%
Visceral Leishmaniasis
31%
Neoplasms
26%
Mitogen-Activated Protein Kinase Kinases
26%
Interleukin-5 Receptors
24%
Aurora Kinase B
22%
Neck
22%
Non-Small Cell Lung Carcinoma
22%
polo-like kinase 1
22%
Flavin Mononucleotide
21%
Dimerization
21%
Head
21%
Squamous Cell Neoplasms
21%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
21%
STAT1 Transcription Factor
20%
Biomarkers
19%
Vaccination
19%
Janus Kinases
19%
Apoptosis
19%
Pharmacogenetics
18%
MEK162
18%
Oxides
17%
src-Family Kinases
17%
Head and Neck Neoplasms
17%
Proteasome Endopeptidase Complex
17%
Leishmania
17%
Membranes
17%
Pharmaceutical Preparations
16%
Lysine
16%
Nitrites
16%
Immunoblotting
16%
Ubiquitination
16%
Transforming Growth Factors
15%
Lung Neoplasms
15%
Endocytosis
14%
Prolactin
14%
Agriculture & Biology
Leishmania donovani
57%
antigens
26%
transforming growth factors
19%
vaccines
17%
mice
17%
Leishmania
16%
vaccination
16%
production economics
16%
choline
16%
immunity
13%
visceral leishmaniasis
12%
phospholipids
12%
infection
11%
interleukin-4
11%
chemical derivatives
11%
splenocytes
10%
delayed hypersensitivity
10%
immunization
9%
macrophages
9%
cell-mediated immunity
7%
promastigotes
7%
T-lymphocytes
6%
spleen
6%
hamsters
5%
antibodies
5%